Does MEDVi take insurance?

Effectively no — MEDVi↗’s published model is cash-pay (tirzepatide $399/month all-in), and insurers essentially never cover compounded GLP-1s regardless of platform. If there is any chance your plan covers a brand GLP-1, check that first — a covered Zepbound or Wegovy prescription beats every cash figure here; the insurance lane lists the programs built for that work.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

For orientation: the verified tirzepatide field spans $215 (NexLife↗) to $597 (LifeMD↗) per month all-in as of 2026-08-09 — a $382 spread for the same molecule, made of structure rather than chemistry — while the brand lane holds $449 at maintenance via Zepbound (LillyDirect↗). Coverage, where a plan grants it, outranks the whole board.

The reading rules behind every number above: figures are all-in (medication plus mandatory fees) at the maintenance dose; prepaid paths are labeled as upfront commitments; stated-not-verified flags mark claims we could not capture on a provider’s own pages; and each record carries its capture date, source link, and archive link so the answer can be checked rather than trusted. Recompute anything here from the public dataset — that reproducibility, not our word, is the warranty.

The insurance lane itself, for orientation: Found, LifeMD, Ro Body, WeightWatchers Clinic are the programs in this index built around coverage work — benefits checks, prior-authorization filings, appeals — and any one of them landing real coverage produces a monthly cost no cash program here can touch. The sequence that wins PA, step by step, is in the coverage playbook; the free first move is always the phone number on your insurance card.

Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.